Ultralife Corp. (NASDAQ: ULBI) reported Q4 EPS of ($0.01), $0.10 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $36.1 million versus the consensus estimate of $37 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.